Laporan Laba Rugi (TTM)
Laporan Laba Rugi Ascendis Pharma A/S - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2023 01-01 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9 | 7 | 5 | 5 | 3 | 8 | 14 | 19 | 33 | 51 | 78 | 119 | 152 | 267 | 329 | 318 | 327 | 364 | 369 | 491 |
| Change (%) | -22.10 | -21.27 | -7.58 | -32.48 | 127.69 | 78.19 | 37.08 | 74.61 | 54.25 | 52.29 | 52.91 | 27.48 | 75.57 | 23.36 | -3.46 | 3.09 | 11.06 | 1.39 | 33.10 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 185 | -58 | -121 | -185 | 4 | 8 | 9 | 11 | 12 | 13 | 24 | 30 | 44 | 47 | 46 | 50 | 44 | 54 | 74 | |
| Change (%) | 110.54 | 52.90 | -101.90 | 120.52 | 13.98 | 19.12 | 15.06 | 3.09 | 94.66 | 23.38 | 47.74 | 6.64 | -3.09 | 8.31 | -10.94 | 22.48 | 36.86 | |||
| % of Revenue | 2,074.53 | -1,050.69 | -2,393.62 | -5,420.14 | 45.29 | 56.05 | 46.61 | 31.80 | 23.72 | 16.05 | 20.44 | 19.78 | 16.64 | 14.39 | 14.44 | 15.18 | 12.17 | 14.70 | 15.12 | |
| Gross Operating Profit | -176 | 7 | 63 | 126 | 189 | 4 | 6 | 10 | 23 | 39 | 65 | 95 | 122 | 222 | 282 | 272 | 278 | 319 | 314 | 417 |
| Change (%) | -103.95 | 805.93 | 100.28 | 49.48 | -97.74 | 43.15 | 66.54 | 123.06 | 72.52 | 67.59 | 44.92 | 28.53 | 82.44 | 26.70 | -3.53 | 2.20 | 15.00 | -1.53 | 32.45 | |
| % of Revenue | -1,974.53 | 100.00 | 1,150.69 | 2,493.62 | 5,520.14 | 54.71 | 43.95 | 53.39 | 68.20 | 76.28 | 83.95 | 79.56 | 80.22 | 83.36 | 85.61 | 85.56 | 84.82 | 87.83 | 85.30 | 84.88 |
| SG&A | 73 | 77 | 96 | 111 | 132 | 160 | 170 | 192 | 213 | 221 | 240 | 254 | 257 | 264 | 265 | 269 | 275 | 291 | 325 | 359 |
| Change (%) | 4.57 | 25.21 | 15.14 | 19.69 | 21.07 | 6.35 | 12.47 | 11.16 | 3.87 | 8.64 | 5.70 | 1.16 | 2.89 | 0.09 | 1.52 | 2.31 | 5.91 | 11.77 | 10.22 | |
| % of Revenue | 821.51 | 1,102.68 | 1,753.76 | 2,185.02 | 3,873.01 | 2,059.40 | 1,229.08 | 1,008.43 | 641.99 | 432.30 | 308.40 | 213.18 | 169.17 | 99.13 | 80.44 | 84.59 | 83.96 | 80.06 | 88.26 | 73.08 |
| R&D | 50 | 261 | 349 | 432 | 491 | 296 | 291 | 298 | 337 | 380 | 403 | 417 | 431 | 413 | 378 | 356 | 319 | 307 | 323 | 311 |
| Change (%) | 418.92 | 33.79 | 23.87 | 13.59 | -39.76 | -1.68 | 2.43 | 12.98 | 12.76 | 6.04 | 3.64 | 3.36 | -4.11 | -8.57 | -5.70 | -10.63 | -3.64 | 5.18 | -3.56 | |
| % of Revenue | 563.34 | 3,752.39 | 6,376.56 | 8,546.33 | 14,377.05 | 3,803.90 | 2,098.92 | 1,568.44 | 1,014.79 | 741.83 | 516.51 | 350.08 | 283.84 | 155.02 | 114.89 | 112.23 | 97.30 | 84.43 | 87.58 | 63.46 |
| OpEx | 309 | 338 | 388 | 422 | 438 | 460 | 469 | 498 | 560 | 613 | 655 | 696 | 718 | 722 | 690 | 671 | 643 | 642 | 703 | 744 |
| Change (%) | 9.34 | 14.80 | 8.84 | 3.90 | 4.86 | 2.06 | 6.27 | 12.39 | 9.43 | 6.92 | 6.13 | 3.26 | 0.56 | -4.46 | -2.75 | -4.15 | -0.12 | 9.36 | 5.94 | |
| % of Revenue | 3,459.38 | 4,855.07 | 7,079.63 | 8,337.73 | 12,829.92 | 5,908.59 | 3,384.06 | 2,623.47 | 1,688.57 | 1,197.85 | 840.96 | 583.70 | 472.79 | 270.79 | 209.72 | 211.27 | 196.44 | 176.66 | 190.54 | 151.66 |
| Operating Income | -300 | -331 | -382 | -417 | -435 | -452 | -455 | -479 | -527 | -562 | -577 | -576 | -566 | -456 | -361 | -353 | -316 | -279 | -334 | -254 |
| Change (%) | 10.27 | 15.56 | 9.08 | 4.34 | 3.90 | 0.75 | 5.33 | 9.92 | 6.60 | 2.79 | -0.18 | -1.75 | -19.56 | -20.75 | -2.10 | -10.66 | -11.72 | 19.75 | -24.06 | |
| % of Revenue | -3,359.38 | -4,755.07 | -6,979.63 | -8,237.73 | -12,729.92 | -5,808.59 | -3,284.06 | -2,523.47 | -1,588.57 | -1,097.85 | -740.96 | -483.70 | -372.79 | -170.79 | -109.72 | -111.27 | -96.44 | -76.66 | -90.54 | -51.66 |
| Interest Expense | -59 | -2 | -2 | -3 | -4 | -25 | -17 | -27 | -31 | -39 | -35 | -41 | -44 | -136 | -133 | -110 | -66 | -33 | -85 | |
| Change (%) | -96.77 | 22.00 | 17.31 | 537.56 | -31.66 | 56.75 | 14.86 | 28.16 | -12.26 | 18.67 | 7.63 | 208.84 | -2.21 | -17.51 | -40.33 | -49.42 | 155.83 | |||
| % of Revenue | -665.01 | -27.59 | -42.75 | -54.26 | -50.28 | -179.91 | -89.69 | -80.52 | -59.96 | -50.46 | -28.95 | -26.95 | -16.52 | -41.36 | -41.90 | -33.53 | -18.01 | -8.99 | -17.27 | |
| Net Income | -360 | -419 | -418 | -458 | -416 | -384 | -446 | -393 | -482 | -583 | -569 | -609 | -602 | -481 | -502 | -490 | -426 | -378 | -342 | -271 |
| Change (%) | 16.26 | -0.13 | 9.43 | -9.04 | -7.90 | 16.35 | -11.89 | 22.53 | 21.04 | -2.50 | 7.05 | -1.11 | -20.02 | 4.18 | -2.40 | -12.87 | -11.35 | -9.63 | -20.64 | |
| % of Revenue | -4,037.56 | -6,025.53 | -7,643.95 | -9,050.64 | -12,192.04 | -4,931.56 | -3,219.94 | -2,069.74 | -1,452.41 | -1,139.63 | -729.60 | -510.81 | -396.27 | -180.51 | -152.44 | -154.12 | -130.26 | -103.97 | -92.67 | -55.25 |
Source: Capital IQ
